Skip to contentO
Opus Genetics, Inc.
O
IRDOpus Genetics, Inc. Q2 2016 · 10-Q
Revenue—
Net Income-$1.77M-$1.77MN/M vs Q2 2015 EPS Diluted-$0.08-$0.08N/M vs Q2 2015 Operating Income-$3,912,782N/M Operating Cash Flowderived-$5,062,744N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 5, 2016 · 36 d after period end